In the last few years, the laboratory of Dr. Niva Russek-Blum located in the Central Arava branch, is leading a reserach in zebrafish carrying a mutation in the SOD1 gene, a valid model for human ALS disease.
In a research led by Dr. Russek- Blum, in collaboration with the Israeli company Neurosense therapeutics, Dr. Gary Armstrong from the Department of Neurology and Neurosurgery at the Montreal Neurological Institute and Prof. Jeremy Shefner from the Barrow Neurological Institute at Dignity Health St. Joseph’s Hospital and Medical Center in Phoenix, remarkable results in the ALS zebrafish model were exhibited, using a unique drug combinationation.
The company is now spearheading to the clinical phase, initiating a compassionate study while preparing to begin a phase II clinical study in ALS patients, to show its efficacy in humans.
To learn more about the study’s results please see the movie.
Dr. Russek- Blum Laboratory: